transplant and ssdi

Have you had a transplant, and if so did you receive ssdi before the tx? Are you still getting ssdi? If not, when did it stop?
Source: Cystic Fibrosis Transplants Forum - Category: Respiratory Medicine Authors: Tags: Transplants Source Type: forums

Related Links:

On 7 October 2020, we withdrew our recommendations on reducing or deprioritising cystic fibrosis registry data entry, limiting transplant services and deferring transition to adult services because these emergency measures are no longer needed.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
Pneumocystis pneumonia (PCP) remains the most frequent AIDS-defining illness in developed countries. This infection also occurs in non-AIDS immunosuppressed patients, e.g., those who have undergone an organ transplantation. Moreover, mild Pneumocystis jirovecii infections related to low pulmonary fungal burden, frequently designated as pulmonary colonization, occurs in patients with chronic pulmonary diseases, e.g., cystic fibrosis (CF). Indeed, this autosomal recessive disorder alters mucociliary clearance leading to bacterial and fungal colonization of the airways. This mini-review compiles and discusses available inform...
Source: Frontiers in cellular and infection microbiology - Category: Microbiology Source Type: research
Authors: Yokoda RT, Rodriguez EA Abstract Cholestatic liver diseases (CLD) begin to develop after an impairment of bile flow start to affect the biliary tree. Cholangiocytes actively participate in the liver response to injury and repair and the intensity of this reaction is a determinant factor for the development of CLD. Progressive cholangiopathies may ultimately lead to end-stage liver disease requiring at the end orthotopic liver transplantation. This narrative review will discuss cholangiocyte biology and pathogenesis mechanisms involved in four intrahepatic CLD: Primary biliary cholangitis, primary sclerosin...
Source: World Journal of Hepatology - Category: Gastroenterology Tags: World J Hepatol Source Type: research
Respiratory infection with nontuberculous mycobacteria (NTM) has become a growing concern in children and young people with cystic fibrosis (CF) [1]. Mycobacterium abscessus, in particular, has been associated with an increased decline in lung function and is a contraindication to lung transplantation in many centers [2,3]. Treatment regimens for M. abscessus are complex, prolonged and associated with significant adverse effects. Epidemiological studies of NTM in children with CF are limited and risk factors for infection are poorly understood.
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: Tags: Short Communication Source Type: research
A man in his mid-20s with cystic fibrosis developed acute vision loss of the left eye following lung transplant. Over a week, visual acuity decreased to no light perception in both eyes. What would you do next?
Source: JAMA Ophthalmology - Category: Opthalmology Source Type: research
Data regarding the prevalence of metallo- β-lactamases (MBLs) among Pseudomonas aeruginosa isolates in cystic fibrosis patients are scarce. Furthermore, there is limited knowledge on the effect of MBL production o...
Source: BMC Infectious Diseases - Category: Infectious Diseases Authors: Tags: Case report Source Type: research
Cystic fibrosis (CF) is a chronic, genetic, incurable disease that affects primarily the respiratory and gastrointestinal systems. End-stage lung disease is the leading cause of death in people with CF, and lu...
Source: BMC Pulmonary Medicine - Category: Respiratory Medicine Authors: Tags: Case report Source Type: research
Exercise is increasingly recognised as an important component of disease management in cystic fibrosis (CF) [1]. Aerobic capacity, in particular the amount of oxygen uptake during maximal exercise (VO2peak), is highly predictive of long-term morbidity and mortality [2 –4]. VO2peak and other metrics calculated from lab-based cardio-pulmonary exercise testing (CPET) such as the ventilatory equivalents for O2 and CO2 (Ve/VO2 and Ve/VCO2 respectively), are strong predictors of hospitalisation [5], death and lung transplantation [4].
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: Source Type: research
Cystic Fibrosis (CF) is the most common life shortening genetic disorder with a worldwide prevalence of about 1 in 4000 births. CF is a multi-organ disease, affecting lungs and digestive system. The daily intensive treatment has multiple components and is considered a heavy burden on patients and their families. Although life expectancy has increased over the past decade and is expected to improve further with promising CFTR modulators, no cure is presently available. Thus far, lung transplantation (LTX) is the only option to overcome respiratory insufficiency, but LTX involves further chronic comorbidities requiring intensive treatment.
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: Source Type: research
Purpose of review The review of infections in lung transplantation is beyond the scope of this article as it is a comprehensive topic, however we aim to focus on infections with multidrug-resistant (MDR) microorganisms in this patient population. Recent findings New emerging clinical studies have provided data regarding outcomes in lung transplant recipients with MDR bacterial infections. Summary Isolation of MDR bacteria from lung donors preoperatively has not been associated with worse outcomes in recipients. Patients with cystic fibrosis colonized with MDR bacteria do not have increased 1 year mortality rates co...
Source: Current Opinion in Organ Transplantation - Category: Surgery Tags: INFECTIOUS DISEASES: Edited by Emily Blodget Source Type: research
More News: Cystic Fibrosis | Respiratory Medicine | Transplants